Urethral cancer differential diagnosis: Difference between revisions
Line 76: | Line 76: | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! rowspan="2" |<small>Diseases</small> | ! rowspan="2" |<small>Diseases</small> | ||
| colspan=" | | colspan="7" |<small>'''Symptoms''' | ||
! colspan="4" |<small>Physical Examination</small> | ! colspan="4" |<small>Physical Examination</small> | ||
! colspan="3" |<small>Diagnostic tests</small> | ! colspan="3" |<small>Diagnostic tests</small> | ||
Line 88: | Line 88: | ||
!<small>Dysuria</small> | !<small>Dysuria</small> | ||
!Weak urine stream | !Weak urine stream | ||
!Mass | |||
!<small>Fever</small> | !<small>Fever</small> | ||
!<small>Tenderness</small> | !<small>Tenderness</small> | ||
Line 103: | Line 104: | ||
| | | | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | |||
| | | | ||
| | | | ||
Line 119: | Line 121: | ||
| align="center" style="background:#F5F5F5;" + | +/– | | align="center" style="background:#F5F5F5;" + | +/– | ||
| align="center" style="background:#F5F5F5;" + |– | | align="center" style="background:#F5F5F5;" + |– | ||
| | |||
| | | | ||
| align="center" style="background:#F5F5F5;" + |– | | align="center" style="background:#F5F5F5;" + |– | ||
Line 136: | Line 139: | ||
| align="center" style="background:#F5F5F5;" + | +/– | | align="center" style="background:#F5F5F5;" + | +/– | ||
| align="center" style="background:#F5F5F5;" + |– | | align="center" style="background:#F5F5F5;" + |– | ||
| | |||
| | | | ||
| align="center" style="background:#F5F5F5;" + |– | | align="center" style="background:#F5F5F5;" + |– | ||
Line 153: | Line 157: | ||
| align="center" style="background:#F5F5F5;" + | +/– | | align="center" style="background:#F5F5F5;" + | +/– | ||
| align="center" style="background:#F5F5F5;" + | +/– | | align="center" style="background:#F5F5F5;" + | +/– | ||
| | |||
| | | | ||
| align="center" style="background:#F5F5F5;" + |– | | align="center" style="background:#F5F5F5;" + |– | ||
Line 170: | Line 175: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | +/– | | align="center" style="background:#F5F5F5;" + | +/– | ||
| | |||
| | | | ||
| align="center" style="background:#F5F5F5;" + |– | | align="center" style="background:#F5F5F5;" + |– | ||
Line 187: | Line 193: | ||
| align="center" style="background:#F5F5F5;" + | +/– | | align="center" style="background:#F5F5F5;" + | +/– | ||
| align="center" style="background:#F5F5F5;" + |– | | align="center" style="background:#F5F5F5;" + |– | ||
| | |||
| | | | ||
| align="center" style="background:#F5F5F5;" + |– | | align="center" style="background:#F5F5F5;" + |– | ||
Line 204: | Line 211: | ||
| align="center" style="background:#F5F5F5;" + | – | | align="center" style="background:#F5F5F5;" + | – | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| | |||
| | | | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 231: | Line 239: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| | |||
| | | | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 259: | Line 268: | ||
! rowspan="2" |<small>Diseases</small> | ! rowspan="2" |<small>Diseases</small> | ||
| colspan="5" |<small>'''Symptoms''' | | colspan="5" |<small>'''Symptoms''' | ||
| | |||
| | | | ||
! colspan="4" |<small>Physical Examination</small> | ! colspan="4" |<small>Physical Examination</small> | ||
Line 270: | Line 280: | ||
!<small>Urgency</small> | !<small>Urgency</small> | ||
!<small>Dysuria</small> | !<small>Dysuria</small> | ||
! | |||
! | ! | ||
!<small>Fever</small> | !<small>Fever</small> | ||
Line 285: | Line 296: | ||
| align="center" style="background:#F5F5F5;" + |– | | align="center" style="background:#F5F5F5;" + |– | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| | |||
| | | | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 309: | Line 321: | ||
| align="center" style="background:#F5F5F5;" + | – | | align="center" style="background:#F5F5F5;" + | – | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| | |||
| | | | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
Line 333: | Line 346: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| | |||
| | | | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + |
Revision as of 18:47, 10 January 2019
Urethral cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Urethral cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Urethral cancer differential diagnosis |
Risk calculators and risk factors for Urethral cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2], Vindhya BellamKonda, M.B.B.S [3]
Overview
Urethral cancer must be differentiated from bladder cancer, cervical cancer, bladder stones, ureteral stones, cystitis, neurogenic bladder, and urethritis.
Differentiation
Urethral cancer must be differentiated from other diseases that cause lower urinary tract irritation symptoms (e.g., dysuria, urgency and frequency in addition to urethral discharge); these include Bladder cancer, Cervical cancer, urethritis, Bladder stones, cystitis, urethrolithiasis, Neurogenic bladder, cervicitis, vulvovaginitis, and epididymitis.[1][2][3][4][5][6][7][8][9][10][11]
Diseases | Symptoms | Physical Examination | Diagnostic tests | Past medical history | Other Findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hematuria | Pyuria | Frequency | Urgency | Dysuria | Weak urine stream | Mass | Fever | Tenderness | Discharge | Inguinal Lymphadenopathy | Urinalysis | Urine Culture | Gold Standard | |||
Urethral Cancer | + | |||||||||||||||
Bladder cancer | + | – | +/– | +/– | – | – | – | – | ||||||||
Cervical cancer | – | – | +/– | +/– | – | – | – | – | ||||||||
Bladder stones | + | – | + | +/– | +/– | – | – | – | ||||||||
Urethrolithiasis | + | – | + | + | +/– | – | – | – | ||||||||
Neurogenic bladder | – | – | +/– | +/– | – | – | – | – | – | |||||||
Urethritis | – | + | – | – | + | + | – | Urethral discharge | + |
|
– | Gram stain & mucoid or purulent discharge |
|
|||
Cystitis | + | + | + | + | + | + | Suprapubic | – | + |
|
>100,000CFU/mL | Urine culture |
|
|||
Diseases | Symptoms | Physical Examination | Diagnostic tests | Past medical history | Other Findings | |||||||||||
Hematuria | Pyuria | Frequency | Urgency | Dysuria | Fever | Tenderness | Discharge | Inguinal Lymphadenopathy | Urinalysis | Urine Culture | Gold Standard | |||||
Vulvovagintis | – | – | – | – | + | + | – | Vaginal discharge | + | – | – | Gram stain & culture of discharge |
|
| ||
Cervicitis | – | + | – | – | + | + | Cervical | Endocervical exudate | – | – | – | Culture for gonococcal cervicitis |
|
| ||
Epididymitis | + | – | + | + | + | + | Testicular & suprapubic | +/– urethral discharge | + |
|
+ | Culture |
|
|
References
- ↑ Stephen Bent, Brahmajee K. Nallamothu, David L. Simel, Stephan D. Fihn & Sanjay Saint (2002). "Does this woman have an acute uncomplicated urinary tract infection?". JAMA. 287 (20): 2701–2710. PMID 12020306. Unknown parameter
|month=
ignored (help) - ↑ W. E. Stamm (1981). "Etiology and management of the acute urethral syndrome". Sexually transmitted diseases. 8 (3): 235–238. PMID 7292216. Unknown parameter
|month=
ignored (help) - ↑ W. E. Stamm, K. F. Wagner, R. Amsel, E. R. Alexander, M. Turck, G. W. Counts & K. K. Holmes (1980). "Causes of the acute urethral syndrome in women". The New England journal of medicine. 303 (8): 409–415. doi:10.1056/NEJM198008213030801. PMID 6993946. Unknown parameter
|month=
ignored (help) - ↑ Leonie G. M. Giesen, Grainne Cousins, Borislav D. Dimitrov, Floris A. van de Laar & Tom Fahey (2010). "Predicting acute uncomplicated urinary tract infection in women: a systematic review of the diagnostic accuracy of symptoms and signs". BMC family practice. 11: 78. doi:10.1186/1471-2296-11-78. PMID 20969801.
- ↑ Taylor-Robinson D (1996). "The history of nongonococcal urethritis. Thomas Parran Award Lecture". Sex Transm Dis. 23 (1): 86–91. PMID 8801649.
- ↑ Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 9781455748013.
- ↑ Brill JR (2010). "Diagnosis and treatment of urethritis in men". Am Fam Physician. 81 (7): 873–8. PMID 20353145.
- ↑ Daniel V. Landers, Harold C. Wiesenfeld, R. Phillip Heine, Marijane A. Krohn & Sharon L. Hillier (2004). "Predictive value of the clinical diagnosis of lower genital tract infection in women". American journal of obstetrics and gynecology. 190 (4): 1004–1010. doi:10.1016/j.ajog.2004.02.015. PMID 15118630. Unknown parameter
|month=
ignored (help) - ↑ Felix Millan-Rodriguez, J. Palou, Anna Bujons-Tur, Mireia Musquera-Felip, Carlota Sevilla-Cecilia, Marc Serrallach-Orejas, Carlos Baez-Angles & Humberto Villavicencio-Mavrich (2006). "Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract". World journal of urology. 24 (1): 45–50. doi:10.1007/s00345-005-0040-4. PMID 16437219. Unknown parameter
|month=
ignored (help) - ↑ Kim TH, Kim SY, Moon KC, Lee J, Cho JY, Kim SH (April 2017). "Clear Cell Adenocarcinoma of the Urethra in Women: Distinctive MRI Findings for Differentiation From Nonadenocarcinoma and Non-Clear Cell Adenocarcinoma of the Urethra". AJR Am J Roentgenol. 208 (4): 805–811. doi:10.2214/AJR.16.16929. PMID 28140610.
- ↑ Cantiello F, Cicione A, Salonia A, Autorino R, Tucci L, Madeo I, Damiano R (May 2013). "Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study". Urology. 81 (5): 1018–23. doi:10.1016/j.urology.2013.01.053. PMID 23608423.